Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Garcίa, Fernando"'
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
Autor:
Seidlitz, Therese, Schmäche, Tim, Garcίa, Fernando, Lee, Joon Ho, Qin, Nan, Kochall, Susan, Fohgrub, Juliane, Pauck, David, Rothe, Alexander, Koo, Bon‐Kyoung, Weitz, Jürgen, Remke, Marc, Muñoz, Javier, Stange, Daniel E.
Gastric cancer ranks the fifth most common and third leading cause of cancer‐related deaths worldwide. Alterations in the RTK/MAPK, WNT, cell adhesion, TP53, TGFβ, NOTCH, and NFκB signaling pathways could be identified as main oncogenic drivers.
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A90812
https://tud.qucosa.de/api/qucosa%3A90812/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A90812/attachment/ATT-0/
Autor:
Seidlitz T; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Schmäche T; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany., Garcίa F; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Lee JH; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Qin N; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany., Kochall S; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Fohgrub J; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Pauck D; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany., Rothe A; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Koo BK; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.; Center for Genome Engineering, Institute for Basic Science, Daejeon, Republic of Korea., Weitz J; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany., Remke M; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany., Muñoz J; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Stange DE; Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2022 Oct 10; Vol. 14 (10), pp. e15705. Date of Electronic Publication: 2022 Aug 22.
